- Home
- PRTA vs GSM Comparison
PRTA vs GSM Comparison
Compare PRTA & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- GSM
- Stock Information
- Founded
- PRTA 2012
- GSM 2015
- Country
- PRTA Ireland
- GSM United Kingdom
- Employees
- PRTA N/A
- GSM N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- GSM Metal Mining
- Sector
- PRTA Health Care
- GSM Basic Materials
- Exchange
- PRTA Nasdaq
- GSM Nasdaq
- Market Cap
- PRTA 809.8M
- GSM 739.5M
- IPO Year
- PRTA N/A
- GSM N/A
- Fundamental
- Price
- PRTA $7.18
- GSM $3.84
- Analyst Decision
- PRTA Buy
- GSM Hold
- Analyst Count
- PRTA 9
- GSM 1
- Target Price
- PRTA $51.71
- GSM N/A
- AVG Volume (30 Days)
- PRTA 1.6M
- GSM 1.1M
- Earning Date
- PRTA 05-08-2025
- GSM 05-07-2025
- Dividend Yield
- PRTA N/A
- GSM 1.45%
- EPS Growth
- PRTA N/A
- GSM N/A
- EPS
- PRTA N/A
- GSM N/A
- Revenue
- PRTA $137,935,000.00
- GSM $1,559,264,000.00
- Revenue This Year
- PRTA N/A
- GSM N/A
- Revenue Next Year
- PRTA $122.59
- GSM $6.90
- P/E Ratio
- PRTA N/A
- GSM N/A
- Revenue Growth
- PRTA 54.55
- GSM N/A
- 52 Week Low
- PRTA $8.00
- GSM $2.97
- 52 Week High
- PRTA $25.42
- GSM $6.19
- Technical
- Relative Strength Index (RSI)
- PRTA 30.36
- GSM 57.33
- Support Level
- PRTA $6.47
- GSM $3.71
- Resistance Level
- PRTA $8.08
- GSM $4.10
- Average True Range (ATR)
- PRTA 0.72
- GSM 0.18
- MACD
- PRTA 0.00
- GSM 0.04
- Stochastic Oscillator
- PRTA 21.60
- GSM 75.47
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About GSM Ferroglobe PLC
Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel and ductile iron foundry industries. The company's business segments include North America - Silicon; Europe - Manganese; Europe - Silicon; South Africa - Silicon and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.